openPR Logo
Press release

Onco-Immunotherapy Market - Latest Trends, Competitive Intelligence & Capability Assessment up to 2025

01-21-2019 07:56 AM CET | Health & Medicine

Press release from: Stratview Research

Onco-Immunotherapy Market - Latest Trends, Competitive

Stratview Research has launched a research report Onco-Immunotherapy Market. The objective of this report is to identify the Trend, Forecast, Competitive Analysis, and Growth Opportunity of Life Science Reagents Market from 2018 to 2025.

This report is segmented in five ways to provide a 360 degree holistic view. The segments are –
• By Variation in Therapy Algorithm – APAC, North America, Western Europe, Rest of The World
• By Epidemiology
• By Class of Drugs - Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors, Immunomodulators, Interferons Alpha, Lung, Breast, Colorectal, Melanoma, Prostate,Head & Neck
• By End-User Location – Hospital, Clinics, Home Based
• By Region –
o North America (Country Analysis: the USA, Canada)
o Western Europe (Country Analysis: Germany, France, the UK)
o Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
o Rest of the World (Sub-Region Analysis: The Middle East, Africa, Rest of Europe and Others)

This report, from Stratview Research, studies the global onco-immunotherapy market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

Click here to request the detailed TOC of the reports:-
https://www.stratviewresearch.com/toc/428/onco-immunotherapy-market.html
OR
Request a sample here:-
https://www.stratviewresearch.com/Request-Sample/428/onco-immunotherapy-market.html

Immunotherapy could be the wonder therapy for cancer
Oncologists believe that Immunotherapy could be that wonder therapy for cancer. Since 2016, this innovation shifted the way in which cancer is treated and has transformed care for many patients. In fact, ASCO estimates that immune checkpoint inhibitors could save 250,000 years of life for the U.S. patients with advanced lung cancer for whom a checkpoint inhibitor could be prescribed. Immune checkpoint inhibitors are medicines that release the brakes on the body’s immune system, unleashing it to fight cancer.

It boosts the body's natural defenses to fight cancer
Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer. It uses substances made by the body or in a laboratory to improve or restore immune system function. This report gives insight on the treatment of cancer patients with immunotherapy across different markets and brings out the gaps between existing way of therapeutics and the demand. It also explores the treatment of different types of cancer i.e. Lung, Breast, Colorectal, Melanoma, Prostate and others using immunotherapy and looks at the regulations, cost, and supply chain issues across the major markets.

Aerial view of the market for the manufacturers
The report gives an aerial view of the market for the manufacturers as well as looks at the demands and gaps at the hospitals for suppliers and distributors. Covering all the major markets where immunotherapy has been approved for the treatment of cancer, this report gives a global insight in to the gaps and opportunities that exist in the market.

Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, Product portfolio, New launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors
• Future outlook

This report studies the global Onco-Immunotherapy Market, keeping in mind the interest of all the stakeholders across the value chain. The rich quality of insights is outcome of -
• Extensive secondary research,
• Rigorous primary interviews with more than 15 industry stakeholders across the value chain.
• Validation and triangulation of data with Stratview Research’s internal database and statistical tools.
• More than 1000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data.

Stratview Research has several high value market reports in the healthcare & life science industry. Please refer to the following link to browse through our reports:
https://www.stratviewresearch.com/market/report/Healthcare-and-Life-Sciences.html

About Stratview Research
Stratview Research is a global market intelligence firm offering a wide range of services including syndicated market reports, consulting, sourcing intelligence, and customer research. We are a trusted brand in the research industry with capability of commissioning complex projects within a short span of time with high level of accuracy.

Stratview Research
400 Renaissance Center,
Suite 2600,
Detroit, Michigan, MI 48243
United States of America
Phone No. +1-313-307-4176
sales@stratviewresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Onco-Immunotherapy Market - Latest Trends, Competitive Intelligence & Capability Assessment up to 2025 here

News-ID: 1515429 • Views:

More Releases from Stratview Research

Semiconductor Vacuum Valve Market Set to Reach US$ 1.0 Billion by 2031, Reports Stratview Research
Semiconductor Vacuum Valve Market Set to Reach US$ 1.0 Billion by 2031, Reports …
Stratview Research, a leading global market research firm, forecasts that the global Semiconductor Vacuum Valve market will grow at an annual rate of 6.7%, reaching US$ 1.0 billion by 2031. The report provides a detailed outlook on regional and global markets, emerging trends, segment analysis, competitive landscape, and key market drivers. Click here to get a free sample of the report: https://www.stratviewresearch.com/Request-Sample/3932/semiconductor-vacuum-valve-market.html#form Key Report Highlights: • Market Size by 2031: US$ 1.0 billion • Growth Rate
Small Satellites Market Set to Reach US$ 7.7 Billion by 2030, Reports Stratview Research
Small Satellites Market Set to Reach US$ 7.7 Billion by 2030, Reports Stratview …
Stratview Research, a leading global market research firm, forecasts that the global Small Satellites market will grow at an annual rate of 2.2%, reaching US$ 7.7 billion by 2030. The report provides a detailed outlook on regional and global markets, emerging trends, segment analysis, competitive landscape, and key market drivers. Click here to get a free sample of the report: https://www.stratviewresearch.com/Request-Sample/1920/small-satellites-market.html#form Key Report Highlights: • Market Size by 2030: US$ 7.7 billion • Growth Rate (CAGR):
Hard Body Armor Market Set to Reach US$ 2,271.2 Million by 2031, Reports Stratview Research
Hard Body Armor Market Set to Reach US$ 2,271.2 Million by 2031, Reports Stratvi …
Stratview Research, a leading global market research firm, forecasts that the global Hard Body Armor market will grow at an annual rate of 3.2%, reaching US$ 2,271.2 million on by 2031. The report provides a detailed outlook on regional and global markets, emerging trends, segment analysis, competitive landscape, and key market drivers. Click here to get a free sample of the report: https://www.stratviewresearch.com/Request-Sample/3253/hard-body-armor-market.html#form Key Report Highlights: • Market Size by 2031: US$ 2,271.2 million • Growth
3D Printing Powder Market Set to Reach US$ 5.8 Billion by 2028, Reports Stratview Research
3D Printing Powder Market Set to Reach US$ 5.8 Billion by 2028, Reports Stratvie …
Stratview Research, a leading global market research firm, forecasts that the global 3D Printing Powder market will grow at an annual rate of 27.1%, reaching US$ 5.8 billion by 2028. The report provides a detailed outlook on regional and global markets, emerging trends, segment analysis, competitive landscape, and key market drivers. Click here to get a free sample of the report: https://www.stratviewresearch.com/Request-Sample/853/3d-printing-powder-market.html#form Key Report Highlights: • Market Size by 2028: US$ 5.8 billion • Growth Rate

All 5 Releases


More Releases for Immunotherapy

Immunotherapy Drugs Market
Immunotherapy Drugs Market Size reached US$ 288.02 Billion in 2024 and is expected to reach US$ 872.64 Billion by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033. The Immunotherapy Drugs Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead
Anti TIGIT Antibodies Revolutionizing Immunotherapy
Anti-TIGIT antibodies are at the forefront of a revolution in immunotherapy, representing a new class of immune checkpoint inhibitors that have the potential to transform the treatment landscape for cancer. Immunotherapy, which harnesses the body's immune system to fight cancer, has already made significant strides with the introduction of PD-1, PD-L1, and CTLA-4 inhibitors. However, the discovery and development of anti-TIGIT antibodies add a new dimension to this field, offering
Allergy Immunotherapy Market Combating the Rising Tide: The Allergy Immunotherap …
Allergy Immunotherapy Market is to reach over USD 4.01 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Region, Market Outlook And Industry Analysis
Allergy Immunotherapy Market - Empowering Resilience, Defying Allergies: Advanci …
Newark, New Castle, USA - new report, titled Allergy Immunotherapy Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Allergy Immunotherapy market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Allergy Immunotherapy market. The report offers an overview of the market, which
Cancer Immunotherapy Market Cancer Immunotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Immunotherapy: Mending Cancer Regimens 1.1 Preface to Cancer Immunotherapy 1.2 Evolution of Cancer Immunotherapy 2. Categorization of Cancer Immunotherapy 2.1 Specific Cancer Immunotherapy 2.1.1 Cancer Vaccines 2.1.2 Monoclonal Antibodies 2.2 Non-Specific Cancer Immunotherapy 2.2.1 Adoptive Cell Transfer Immunotherapy 2.2.2 Immune Checkpoint Inhibitors 3. Fundamentals
Global Cancer Immunotherapy Market & Cancer Immunotherapy Clinical Trials Outloo …
Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies because of large unmet medical necessities. Investigators are trying to come forth with innovative cancer immunotherapeutic products having high safety and efficacy profiles which are not offered by conventional therapeutics. Higher investments in research and development segment could significantly increase the drug discovery rates which will alleviate the medical condition of cancer patients. Simultaneously, technological advancements are being